Skip to Main Content

Paper Details

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
2
2023
Author NameAffiliation
Young K SongNational Cancer Institute, National Institutes of Health
Young K SongNational Cancer Institute, National Institutes of Health
Poul H SorensenBritish Columbia Cancer Research Centre
Poul H SorensenBritish Columbia Cancer Research Centre
Dimiter S DimitrovUniversity of Pittsburgh Department of Medicine
John M MarisChildren's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania
John M MarisChildren's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania
Javed KhanNational Cancer Institute, National Institutes of Health
Javed KhanNational Cancer Institute, National Institutes of Health
  • 1 - 9

Datasets